Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial-Reference-Cited by-同舟云学术

Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial

Published:2018-03 Issue: Volume:197 Page:1-8
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Sherwood Matthew W.,Lopes Renato D.,Sun Jie Lena,Liaw Danny,Harrington Robert A.,Wallentin Lars,Laskowitz Daniel T.,James Stefan K.,Goodman Shaun G.,Darius Harald,Lewis Basil S.,Gibson C. Michael,Pieper Karen S.,Alexander John H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Ischemic stroke after acute myocardial infarction. A population-based study;Mooe;Stroke,1997

2. 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)

3. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;Circulation,2013

4. Warfarin, aspirin, or both after myocardial infarction;Hurlen;N Engl J Med,2002

5. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-01-24

2. A narrative review of low-dose rivaroxaban in patients with atherothrombotic cardiovascular disease: vascular protection beyond anticoagulation;Cardiovascular Diagnosis and Therapy;2021-02

3. Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy;Atherosclerosis;2020-12

4. A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention;Expert Opinion on Drug Safety;2019-10-08

5. Incidence and predictors of stroke in patients discharged with the diagnosis of acute coronary syndrome;International Journal of Cardiology;2019-02